SPYG

COM:SPYGLASSPHARMA

Spyglass Pharma

  • Privately Held

Spyglass Pharma develops an IOL-mounted, controlled release drug delivery platform for delivering multiple years of therapy. The company is targeting a 3-year delivery of bimatoprost to treat glaucoma in patients undergoing cataract surgery.

peer of

investor of